Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 148.55 billion. The enterprise value is 166.97 billion.

Market Cap	148.55B
Enterprise Value	166.97B

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.24%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.51B

Valuation Ratios

The trailing PE ratio is 10.86.

PE Ratio	10.86
Forward PE	n/a
PS Ratio	2.90
PB Ratio	4.01
P/TBV Ratio	22.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.58, with an EV/FCF ratio of 11.55.

EV / Earnings	12.21
EV / Sales	3.48
EV / EBITDA	7.58
EV / EBIT	8.97
EV / FCF	11.55

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.83.

Current Ratio	1.36
Quick Ratio	0.87
Debt / Equity	0.83
Debt / EBITDA	1.30
Debt / FCF	2.11
Interest Coverage	19.58

Financial Efficiency

Return on equity (ROE) is 40.79% and return on invested capital (ROIC) is 19.62%.

Return on Equity (ROE)	40.79%
Return on Assets (ROA)	13.90%
Return on Invested Capital (ROIC)	19.62%
Return on Capital Employed (ROCE)	28.06%
Revenue Per Employee	692,642
Profits Per Employee	184,764
Employee Count	75,000
Asset Turnover	0.57
Inventory Turnover	2.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.14% in the last 52 weeks. The beta is 0.70, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-17.14%
50-Day Moving Average	56.55
200-Day Moving Average	58.06
Relative Strength Index (RSI)	52.14
Average Volume (20 Days)	72,372

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.17

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 51.26 billion and earned 13.67 billion in profits. Earnings per share was 5.38.

Revenue	51.26B
Gross Profit	39.52B
Operating Income	19.88B
Pretax Income	15.92B
Net Income	13.67B
EBITDA	23.27B
EBIT	19.88B
Earnings Per Share (EPS)	5.38

Full Income Statement

Balance Sheet

The company has 10.93 billion in cash and 30.57 billion in debt, giving a net cash position of -19.63 billion.

Cash & Cash Equivalents	10.93B
Total Debt	30.57B
Net Cash	-19.63B
Net Cash Per Share	n/a
Equity (Book Value)	37.04B
Book Value Per Share	14.64
Working Capital	8.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.15 billion and capital expenditures -2.69 billion, giving a free cash flow of 14.45 billion.

Operating Cash Flow	17.15B
Capital Expenditures	-2.69B
Free Cash Flow	14.45B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.09%, with operating and profit margins of 38.79% and 26.68%.

Gross Margin	77.09%
Operating Margin	38.79%
Pretax Margin	31.07%
Profit Margin	26.68%
EBITDA Margin	45.40%
EBIT Margin	38.79%
FCF Margin	28.20%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	45.80%
Buyback Yield	0.24%
Shareholder Yield	0.24%
Earnings Yield	9.20%
FCF Yield	9.73%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.65.

Altman Z-Score	4.65
Piotroski F-Score	n/a